Eversense Sensor Insertion and Removal Instructions
Review this step-by-step guide on how to place and remove an Eversense sensor. After appropriate training, in office sensor placement takes less than 15 minutes. Physicians, nurse practitioners and physicians’ assistants can all receive training.
Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System
Learn which prescription drugs interfere with the functioning of the Eversense sensor in this report from the National Center for Biotechnology Information (NCBI.)
THE PRECISE (EUROPEAN) TRIAL - 2015
The PRECISE, 180-day clinical trial was performed at 7 clinical sites in Europe and included 71 participants with Type 1 and Type 2 diabetes. Results demonstrated the safety and accuracy of the Eversense implantable CGM system and supported it as an alternative to transcutaneous CGM.
ACCEPTABILITY OF IMPLANTABLE CGM (EUROPE) - 2017
This European study included 51 participants with Type 1 and Type 2 diabetes. It showed that the Eversense CGM with under-the-skin sensor was widely accepted by users and favorably evaluated by a high percentage of participants in the study.
THE PRECISION TRIAL (U.S) - 2018
This 90-day trial included 35 adults with Type 1 and Type 2 diabetes and was designed to provide additional data on the Eversense CGM system with regard to accuracy and safety. Findings confirmed the accuracy and safety of the implantable sensor throughout the sensor life and showed a slight increase in accuracy in the very low hypoglycemic range.